Fighting to retain its multibillion-dollar market in anemia drugs, Amgen has released new data that shows Aranesp is safe and effective for treating anemia in cancer patients. Report [1]
Links:
[1] http://www.fiercebiotech.com/story/spotlight-keryx-drug-best-at-low-dose/2005-11-14